IMPRINT BIO
LIVE

Serial Number

98785816

Owner

Imprint Labs, LLC

Attorney

Stacy E. Don

Filing Date

Oct 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

IMPRINT BIO Trademark

Serial Number: 98785816

IMPRINT BIO is a trademark filed by Imprint Labs, LLC on October 4, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Imprint Labs, LLC (9 trademarks)

180 Varick Street, Unit 814
New York, NY 10014

Entity Type: 16

Trademark Details

Filing Date

October 4, 2024

Registration Date

Not Registered

Published for Opposition

February 17, 2026

Goods & Services

Creating, designing and improving of datasets, namely data analysis, computational modeling, and data compiling for training artificial intelligence (AI) models and large language models (LLM) to learn patterns and make predictions and data models and training data for identifying druggable targets, antibody sequences and cell therapies in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease for drug, biologics, and vaccine design purposes in the field of medical science and medical consultancy; Providing temporary use of online non-downloadable software for searching, reviewing, analyzing, testing, predicting, inferring, reconstructing, organizing, screening and sharing data, methodologies, and protocols in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease; Providing temporary use of online non-downloadable software for searching, reviewing, analyzing, testing, predicting, inferring, reconstructing, organizing, screening and sharing data, methodologies, and protocols in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease, namely for generating synthetic or experimental dataset-based digital immune twins; Providing an online database comprising scientific information in the field of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease collected for training artificial intelligence (AI) models, machine learning models and large language models (LLM) to learn patterns and make predictions for drug, biologics, and vaccine design purposes in the field of medical science and medical consultancy; Providing information about computer computational modeling of methods regarding machine learning, artificial intelligence (AI) training data, large language models (LLM) to learn patterns and make predictions for identifying etiology, treatment, and prophylaxis of chronic diseases, autoimmunity, psychiatric, neurological disorders, allergy, and infectious disease

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 14, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 26, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 26, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 26, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 26, 2026 CNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 9, 2025 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 3, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2025 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 29, 2025 GNFN
FINAL REFUSAL E-MAILED
Jul 29, 2025 GNFR
FINAL REFUSAL WRITTEN
Jul 29, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 21, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2024 NWOS
NEW APPLICATION ENTERED
Oct 4, 2024 NWAP